Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Huang Jiefu is active.

Publication


Featured researches published by Huang Jiefu.


Chinese Journal of Cancer Research | 1994

Two-stages resection for advanced hepatocellular carcinoma

Liang Lijian; Lu mingde; Huang Jiefu; Peng Bao-gang

We performed two-stage resection for sixteen patients with advanced hepatocellular carcinoma from January, 1987 to July, 1991. All patients underwent various surgical therapies prior to resection which included gauze packing hemostasis in 1 case, hyperthermia plus radiotherapy in 1, hepatic arterial ligation in 2, operative hepatic arterial embolization in 3, and transcatheter embolization in 9. The median interval between the first therapy and tumour resection was 59 days with a range of 29--769 days, and the median diameter of tumours decreased from 10.5 cm to 7.5 cm. The majority of precedures on two-stage resection were irregular hepatectomy or Iobectomy under occlusion of porta hepatis. Regular hepatectomies were done in 4 cases. Pathalogical examination showed complete coagulation necrosis in 3 specimens. However, in the others were still found residual viable tumours. Survival periods of the patients who received two-stage resection were from 4 months to 4 years except 2 operative death. The significance, possibility as well as methods of two-stage resection were discussed.We performed two-stage resection for sixteen patients with advanced hepatocellular carcinoma from January, 1987 to July, 1991. All patients underwent various surgical therapies prior to resection which included gauze packing hemostasis in 1 case, hyperthermia plus radiotherapy in 1, hepatic arterial ligation in 2, operative hepatic arterial embolization in 3, and transcatheter embolization in 9. The median interval between the first therapy and tumour resection was 59 days with a range of 29--769 days, and the median diameter of tumours decreased from 10.5 cm to 7.5 cm. The majority of precedures on two-stage resection were irregular hepatectomy or Iobectomy under occlusion of porta hepatis. Regular hepatectomies were done in 4 cases. Pathalogical examination showed complete coagulation necrosis in 3 specimens. However, in the others were still found residual viable tumours. Survival periods of the patients who received two-stage resection were from 4 months to 4 years except 2 operative death. The significance, possibility as well as methods of two-stage resection were discussed.


Chinese Journal of Cancer Research | 1994

The technique of the normothermic and hypothermic total hepatic vascular exclusion for resection of the liver tumors

Huang Jiefu; Li Guisheng; Chen Bingxue; Xie Xiaoyan; He Xiaoshun

The technique for bloodless hepatic resection using the total hepatic vascular isolation under the normothermic or hypothermic perfusion was reported to deal with the large liver tumor involving in the liver hilum, the main hepatic veins or the retrohepatic vena cava.The original Heaneys and Fortners methods were modified so that the technique could be simpler and more practicable to perform otherwise hazardous liver resection. During the past 4 year, major hepatic resection with the normothermic or hypothermic total vascular exclusion technique was successfully performed on 19 patients with liver tumors in our department. Among the 19 cases, 16 underwent hepatic resection with the normothermic selective total vascular exclusion (extended right lobectomy in 5 cases, extended left lobectomy in 3 cases; right lobectomy in 5 cases; central segmentectomy in 3 cases) and 3 with the total vascular isolation and in situ cold perfusion (extended left lobectomy in 2 case, extended right lobectong in 1 case). We believe that the technique of normothermic vascular exclusion may be indicated to deal with the lesion close to the hepatic veins and the retrohepatic vena cava. However, for more complicated hepatic resection, the hypothermic perfusion technique should be considered to prolong the safety of ischemic time of the liver. The preliminary experience in the clinical application using the above technique is reported.


Chinese Journal of Cancer | 2001

Study on Improving the Techniques of Microwave Coagulation in Treatment of Patients with Large Liver Cancer

Huang Jiefu


Chinese Medical Journal | 2016

中国における臓器移植の新時代【Powered by NICT】

Huang Jiefu; Wang Haibo; Zheng Shusen; Liu Yongfeng; Shi Bingyi; Shen Zhongyang; Hu Shengshou; Ye Qifa; Xue Wujun; He Xiaoshun; Chen Jingyu; Huo Feng; Du Bing; Fan Jing; Guo Yanhong; Zhang Zongjiu


Chinese Journal of Hepatobiliary Surgery | 2010

Sirolimus conversion in liver transplant recipients with calcineurin inhibitor-related renal insufficiency after liver transplantation

Ju Weiqiang; He Xiaoshun; Wang Dongping; Wu Linwei; Tai Qiang; Hu Anbin; Han Ming; Zhu Xiaofeng; Huang Jiefu


Chinese Journal of Digestive Surgery | 2010

Evaluation of liver grafts with warm ischemia and with different cold preservation time in liver transplantation.

Ju Weiqiang; He Xiaoshun; Wu ZhiPeng; Wu Linwei; Tai Qiang; Wang Dongping; Zhu Xiaofeng; Huang Jiefu


Zhongguo Bingli Shengli Zazhi | 2008

転写因子T-BET発現はヒト樹状細胞ワクチンにより誘導される抗肝癌免疫を増強する。【JST・京大機械翻訳】

Chen Zubing; Ding Youming; Tao Jianping; Liang Lijian; Liu Xiaoping; Huang Jiefu


Zhongguo Bingli Shengli Zazhi | 2008

【結語】QUEは,HEPG2細胞のFAS発現を調整し,アポトーシスを誘発する。【JST・京大機械翻訳】

Zhang Jihong; Liang Lijian; Huang Jiefu


Zhongguo Bingli Shengli Zazhi | 2008

IN SITUマイクロ波アブレーションは抗肝癌免疫反応の誘導に有効な抗原を提供する。【JST・京大機械翻訳】

Kuang Ming; Lu Mingde; Zhou Qi; Peng Bao-gang; Liang Lijian; Huang Jiefu


Chinese Journal of Pathophysiology | 2006

Tumor vaccine:a practical formulation with cytokine-microspheres for immunotherapy of hepatocellular carcinoma

Huang Jiefu

Collaboration


Dive into the Huang Jiefu's collaboration.

Top Co-Authors

Avatar

He Xiaoshun

Sun Yat-sen University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ju Weiqiang

Sun Yat-sen University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chen Bingxue

Sun Yat-sen University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Li Guisheng

Sun Yat-sen University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Lu Mingde

Sun Yat-sen University

View shared research outputs
Top Co-Authors

Avatar

Xie Xiaoyan

Sun Yat-sen University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge